Understanding how the perception of risks and benefits influences cancer clinical trial withdrawal outcomes

byUniversity of Pennsylvania School of NursingCredit: Unsplash/CC0 Public DomainWhile people with cancer have options to participate in cancer clinical trials (CCTs), it can be challenging when

Updated on: December 28,2023

Understanding how the perception of risks and benefits influences cancer clinical trial withdrawal outcomes

byUniversity of Pennsylvania School of NursingCredit: Unsplash/CC0 Public DomainWhile people with cancer have options to participate in cancer clinical trials (CCTs), it can be challenging when

Updated on:December 28,2023

Researchers urge caution in co-prescribing potency drugs and nitrates

by Karolinska InstitutetCredit:Journal of the American College of Cardiology(2024). DOI: 10.1016/j.jacc.2023.10.041Co-prescribing potency drugs such as Viagra and organic nitrates for

Updated on: May 06,2024

Researchers urge caution in co-prescribing potency drugs and nitrates

by Karolinska InstitutetCredit:Journal of the American College of Cardiology(2024). DOI: 10.1016/j.jacc.2023.10.041Co-prescribing potency drugs such as Viagra and organic nitrates for

Updated on:May 06,2024

New system for treating colorectal cancer can lead to complete cure

by Society of Nuclear Medicine and Molecular ImagingLeft: Tumor growth presented as the change in tumor volume for each individual mouse over time (green: no treatment; blue: 177Lu-DOTA-Bn only; red:

Updated on: April 10,2024

New system for treating colorectal cancer can lead to complete cure

by Society of Nuclear Medicine and Molecular ImagingLeft: Tumor growth presented as the change in tumor volume for each individual mouse over time (green: no treatment; blue: 177Lu-DOTA-Bn only; red:

Updated on:April 10,2024

New pancreatic cancer treatment proves effective in shrinking, clearing tumors

byUniversity of Massachusetts AmherstPancreatic cancer cells (blue) growing as a sphere encased in membranes (red). Credit: National Cancer InstituteResearchers at the University of Massachusett

Updated on: September 07,2024

New pancreatic cancer treatment proves effective in shrinking, clearing tumors

byUniversity of Massachusetts AmherstPancreatic cancer cells (blue) growing as a sphere encased in membranes (red). Credit: National Cancer InstituteResearchers at the University of Massachusett

Updated on:September 07,2024

Proteogenomics analysis of high-grade gliomas offers hints on tumor evolution

byJosep Carreras Leukaemia Research InstituteGraphical abstract. Credit:Cancer Cell(2024). DOI: 10.1016/j.ccell.2024.06.004In August 2023, a team of researchers including Dr. Eduard

Updated on: July 11,2024

Proteogenomics analysis of high-grade gliomas offers hints on tumor evolution

byJosep Carreras Leukaemia Research InstituteGraphical abstract. Credit:Cancer Cell(2024). DOI: 10.1016/j.ccell.2024.06.004In August 2023, a team of researchers including Dr. Eduard

Updated on:July 11,2024

Updates: MET targeted therapy for EXON 14 mutations in lung cancer

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainAnew editorial papertitled "Latest updates on MET targeted therapy for EXON 14 mutations in lung cancer" has been published

Updated on: March 21,2024

Updates: MET targeted therapy for EXON 14 mutations in lung cancer

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainAnew editorial papertitled "Latest updates on MET targeted therapy for EXON 14 mutations in lung cancer" has been published

Updated on:March 21,2024

Researchers uncover potential novel therapeutic targets against natural killer/T-cell lymphoma

by National University of SingaporePotential new therapeutic targets in NKTL. Credit: Dr Jianbiao ZhouA team of researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the N

Updated on: January 28,2024

Researchers uncover potential novel therapeutic targets against natural killer/T-cell lymphoma

by National University of SingaporePotential new therapeutic targets in NKTL. Credit: Dr Jianbiao ZhouA team of researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the N

Updated on:January 28,2024

Trial results show PARP inhibitor benefit in 'BRCA-like' breast cancer

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainResults from the SWOG S1416 clinical trial show that adding veliparib to chemotherapy can significantly extend progression-free surviva

Updated on: January 04,2024

Trial results show PARP inhibitor benefit in 'BRCA-like' breast cancer

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainResults from the SWOG S1416 clinical trial show that adding veliparib to chemotherapy can significantly extend progression-free surviva

Updated on:January 04,2024

Treatment strategies for adenoid cystic carcinoma of the head and neck

by Impact Journals LLCCT-scan in a coronal section showing an adenoid cystic carcinoma as an inhomogeneous mass in the rightmaxillary sinus with infiltration of neighboring structures. Credit: 2023 Du

Updated on: January 07,2024

Treatment strategies for adenoid cystic carcinoma of the head and neck

by Impact Journals LLCCT-scan in a coronal section showing an adenoid cystic carcinoma as an inhomogeneous mass in the rightmaxillary sinus with infiltration of neighboring structures. Credit: 2023 Du

Updated on:January 07,2024

CAR-T found to be safe and effective on an outpatient basis in community hospitals

byAmerican Society of HematologyCredit: CC0 Public DomainIn the largest prospective study to date examining the use of chimeric antigen receptor (CAR)-T therapy in a community setting on an outp

Updated on: October 26,2024

CAR-T found to be safe and effective on an outpatient basis in community hospitals

byAmerican Society of HematologyCredit: CC0 Public DomainIn the largest prospective study to date examining the use of chimeric antigen receptor (CAR)-T therapy in a community setting on an outp

Updated on:October 26,2024

Identifying the underlying causes of ovarian cancer

byCedars-Sinai Medical CenterSimon Gayther, PhD, professor of Biomedical Sciences, and Michelle Jones, PhD, a research scientist in the Center for Bioinformatics and Functional Genomics, led the

Updated on: January 02,2024

Identifying the underlying causes of ovarian cancer

byCedars-Sinai Medical CenterSimon Gayther, PhD, professor of Biomedical Sciences, and Michelle Jones, PhD, a research scientist in the Center for Bioinformatics and Functional Genomics, led the

Updated on:January 02,2024

New biotechnology combines targeted and immune therapies to kill treatment-resistant cancer cells

byNYU Langone HealthBinding profiles soto-p7/A03 (top row) and p7WT/A03 (bottom row) of clone R011 (left column), the naïve deep mutational scanning library (middle column), and the pool after s

Updated on: January 12,2024

New biotechnology combines targeted and immune therapies to kill treatment-resistant cancer cells

byNYU Langone HealthBinding profiles soto-p7/A03 (top row) and p7WT/A03 (bottom row) of clone R011 (left column), the naïve deep mutational scanning library (middle column), and the pool after s

Updated on:January 12,2024